ROXBURY, NJ - Two clinical trials at Memorial Sloan Kettering Cancer Center will be receiving money raised April 29 at the Layups 4 Life charity basketball tournament that took place in Roxbury, said the organizer.
The trials will share $23,641 said Dan Exter, a former Roxbury resident who survived cancer and began the yearly 3-on-3 basketball tournament as a way to give back to Memorial Sloan Kettering.
Exter said the first clinical trial, called "Stey by Step: Stem Cell Approach Provides New Models for Studying How Acute Myeloid Leukemia Progresses, is led by Dr. Michael Kharas.
"Dr. Michael Kharas's study provides a new method on how we study acute myeloid leukemia (AML) and better understand the step-by-step progression of this disease. In this study," Exter said. He said the team will produce a series of models that replicate each stage of AML.
"This provides an important new tool for developing drugs to treat AML, as well as for finding ways to control and manage other pre-leukemic blood diseases like myelodysplastic syndromes (MDS)," Exter said. To read more about Dr. Kharas's study, CLICK HERE
The other clinical trial is "Phase II -Transplants from Donors, with T-cell Depleted Peripheral Blood Stem Cells using CliniMACS System for Patients with Hematologic Malignancies and Disorders," Exter said. That trial is being led by Dr. Richard J. O'Reilly and Dr. Guenther Koehne.
Their study "is focused on combating graft-versus-host disease (GvHD) which is a complication from stem cell transplantation," Exter said. "GvHD is caused when cells from the donor view the recipient’s cells as foreign, resulting in symptoms such as rash, diarrhea, nausea, and vomiting, among others. To read more about Dr. O'Reilly & Dr. Koehne's study, CLICK HERE
"Layups 4 Life is extremely proud to support these doctor's ground breaking research and be on the forefront of the fight against cancer," Exter said. He thanked all those who contributed, and played at, the event, commenting, "Thank you for taking the courts with us in the fight against this disease - Without YOU, this would not be possible."